M. Ogino

M. Ogino, N. Kanazawa, F. Sakai, 2004, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Culturally Adapted Consensus Definition and Action Guideline: Japan's Advance Care Planning.

T. Morita, M. Ogino, Akemi Yamagishi, 2022, Journal of pain and symptom management.

Sniff Nasal Inspiratory Pressure in Healthy Japanese Subjects: Mean Values and Lower Limits of Normal

M. Ogino, N. Kamide, Michinari Fukuda, 2008, Respiration.

Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection

M. Ogino, Hiroaki Ito, N. Kanazawa, 1996, Journal of Neuroimmunology.

Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients

E. Nagata, M. Ogino, F. Yoshii, 2016, PloS one.

Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness

K. Campbell, I. Nonaka, Y. Hayashi, 2006, Annals of neurology.

Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy

T. Toyota, K. Arimura, M. Ogino, 2011, Journal of NeuroVirology.

Detection of serum anti-ganglioside antibodies by latex agglutination assay in Guillain-Barré syndrome: comparison with ELISA.

M. Ogino, N. Kanazawa, F. Sakai, 2003, Internal medicine.

Treatment and comorbidities of multiple sclerosis in an employed population in Japan: analysis of health claims data.

M. Ogino, I. Kawachi, Shuichi Okamoto, 2018, Neurodegenerative disease management.

Specificity and cross-reactivity of anti-galactocerebroside antibodies.

N. Latov, M. Ogino, S. Apostolski, 1995, Immunological investigations.

Prevalence, treatments and medical cost of multiple sclerosis in Japan based on analysis of a health insurance claims database

M. Ogino, I. Kawachi, Shuichi Okamoto, 2017, Clinical & experimental neuroimmunology.

I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3β signaling pathway.

H. Okano, A. Takashima, Y. Okada, 2015, Human molecular genetics.

ALSUntangled: Introducing The Table of Evidence

R. Conwit, J. Licht, P. Andersen, 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Opinions of Japanese and American ALS caregivers regarding tracheostomy with invasive ventilation (TIV)

Hiroshi Mitsumoto, R. Goetz, J. Rabkin, 2016, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Y. Itoyama, S. Tsuji, G. Sobue, 2017, The Lancet Neurology.

Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: A multicenter study in Japan

Y. Kuroiwa, Toshio Shimizu, T. Komori, 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica

T. Kanda, K. Fujihara, J. Kira, 2016, Multiple sclerosis.

Tracheostomy with invasive ventilation for ALS patients: Neurologists’ roles in the US and Japan

Hiroshi Mitsumoto, Mitsuya Morita, R. Goetz, 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) for Japanese ALS and FTD patients

R. Hanajima, K. Nakashima, M. Ogino, 2020, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.

[Survey report on end-of-life care for ALS patients of ALS physicians in Japan].

M. Ogino, 2010, Rinsho shinkeigaku = Clinical neurology.

ALSUntangled No. 26: Lunasin

R. Conwit, J. Licht, P. Andersen, 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration.

ALS patients with ability to communicate after long-term mechanical ventilation have confined degeneration to the motor neuron system

Toshio Shimizu, M. Hasegawa, I. Nakano, 2016, Journal of the Neurological Sciences.

Syntactic Comprehension in Patients with Amyotrophic Lateral Sclerosis

M. Ogino, Michinari Fukuda, Wakana Hata, 2014, Behavioural neurology.

Loss of DARPP-32 and calbindin in multiple system atrophy

M. Takada, A. Kawanami, M. Saegusa, 2013, Journal of Neural Transmission.

Lewy body pathology in a patient with a homozygous Parkin deletion

Y. Shimo, N. Hattori, M. Saegusa, 2013, Movement disorders : official journal of the Movement Disorder Society.

Prescription pattern of anti-Parkinson's disease drugs in Japan based on a nationwide medical claims database

Masahiko Suzuki, M. Ogino, A. Hayashi, 2020, eNeurologicalSci.

Cognitive and behavioral status in Japanese ALS patients: a multicenter study

R. Hanajima, G. Sobue, Toshio Shimizu, 2020, Journal of Neurology.

Occurrence of cholelithiasis and cholecystitis in amyotrophic lateral sclerosis patients with long-term tracheostomy invasive ventilation.

M. Ogino, E. Kitamura, 2011, Internal medicine.

Adherence to treatment guideline recommendations for Parkinson’s disease in Japan: A longitudinal analysis of a nationwide medical claims database between 2008 and 2016

Masahiko Suzuki, M. Ogino, A. Hayashi, 2020, PloS one.

Japanese version of the ALS-FTD-Questionnaire (ALS-FTD-Q-J)

G. Sobue, Toshio Shimizu, K. Nakashima, 2016, Journal of the Neurological Sciences.

Pathological and immunoblot analysis of phosphorylated TDP‐43 in sporadic amyotrophic lateral sclerosis with pallido‐nigro‐luysian degeneration

M. Hasegawa, S. Murayama, M. Ogino, 2018, Neuropathology : official journal of the Japanese Society of Neuropathology.

Current treatment status and medical cost for multiple sclerosis based on analysis of a Japanese claims database

M. Ogino, I. Kawachi, Hiroyuki Ohta, 2016, Clinical & experimental neuroimmunology.

Efficacy of methylprednisolone pulse therapy for acute relapse in Japanese patients with multiple sclerosis and neuromyelitis optica: A multicenter retrospective analysis – 1. Whole group analysis

T. Kanda, K. Fujihara, J. Kira, 2013 .

ALSUntangled No. 34: GM604.

Gary L. Pattee, R. Conwit, J. Licht, 2016, Amyotrophic lateral sclerosis & frontotemporal degeneration.

ALSUntangled No. 29: MitoQ

R. Conwit, J. Licht, P. Andersen, 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Evaluation of cosmetic acupuncture from MRI imaging: A pilot study focusing on the masseter muscle and superficial fascia

M. Ogino, K. Abe, A. Sakamoto, 2021, Zen Nihon Shinkyu Gakkai zasshi (Journal of the Japan Society of Acupuncture and Moxibustion).

Small-cell carcinoma of the esophagus associated with a paraneoplastic neurological syndrome: a case report documenting a complete response.

M. Azuma, S. Tanabe, K. Saigenji, 2006, Japanese journal of clinical oncology.

Teaching “medical interview and physical examination” from the very beginning of medical school and using “escape rooms” during the final assessment: achievements and educational impact in Japan

M. Ogino, A. Hegab, Haruko Akatsu, 2022, BMC medical education.

ALSUntangled No. 36: Accilion

Gary L. Pattee, R. Conwit, J. Licht, 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial

Annelot M. Dekker, A. Destée, S. Bates, 2017, The Lancet Neurology.

Lewy body pathology in a patient with a homozygous Parkin deletion

Y. Shimo, N. Hattori, M. Saegusa, 2013, Movement disorders : official journal of the Movement Disorder Society.

The identi ﬁ ed clinical features of Parkinson's disease in homo-, heterozygous and digenic variants of PINK1

H. Kusaka, H. Yoshino, Y. Takiyama, 2022 .